Cantharidin Overcomes Imatinib Resistance by Depleting BCR-ABL in Chronic Myeloid Leukemia

Cantharidin (CTD) is an active compound isolated from the traditional Chinese medicine blister beetle and displayed anticancer properties against various types of cancer cells. However, little is known about its effect on human chronic myeloid leukemia (CML) cells, including imatinib-resistant CML c...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xiaoyan, Cai, Xueting, Yang, Jie, Chen, Jiao, Guo, Caixia, Cao, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Molecular and Cellular Biology 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223104/
https://www.ncbi.nlm.nih.gov/pubmed/27989101
http://dx.doi.org/10.14348/molcells.2016.0023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223104/
https://www.ncbi.nlm.nih.gov/pubmed/27989101
http://dx.doi.org/10.14348/molcells.2016.0023

Ejemplares similares